New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026
Century Therapeutics Selected for Oral Presentation of CNTY?813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions
IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes
Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
LaFleur Minerals Engages Maximus Strategic Consulting Inc. for Investor Relations and Marketing Services
West High Yield Resources Receives BC Ministry of Transportation and Transit Access Permit for Record Ridge Magnesium Project and Announces Second Tranche Closing of Private Placement
Nine Mile Metals Announces Completion of DDH WD-26-01, Intersecting 129.72 Meters of Visual Mineralization and Identifies Two Massive Sulphide Zones
